Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (vol 21, pg 290, 2014)

被引：0
|
作者：
Gan, R.
Yang, Y.
Yang, X.
Zhao, L.
Lu, J.
Meng, Q. H.
机构：
[1] Wenzhou Medical University School of Laboratory Medicine and Life Sciences,Key Laboratory of Laboratory Medicine
[2] Ministry of Education,Department of Laboratory Medicine
[3] Zhejiang Provincial Key Laboratory of Medical Genetics,undefined
[4] The University of Texas MD Anderson Cancer,undefined
来源：
CANCER GENE THERAPY | 2023年 / 30卷 / 11期
关键词：
D O I：
10.1038/s41417-023-00672-5
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1582 / 1582
页数：1
相关论文
共 50 条
  • [21] Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer (vol 9, e99067, 2014)
    Wang, Haiji
    Xu, Chunyuan
    Kong, Xiaoli
    Li, Xiaoyan
    Kong, Xiangnan
    Wang, Yu
    Ding, Xia
    Yang, Qifeng
    PLOS ONE, 2019, 14 (03):
  • [22] RETRACTION: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer (Retraction of Vol 33, Pg 4985, 2014)
    Zheng, X. Q.
    Guo, J. P.
    Yang, H.
    Kanai, M.
    He, L. L.
    Li, Y. Y.
    Koomen, J. M.
    Minton, S.
    Gao, M.
    Ren, X. B.
    Coppola, D.
    Cheng, J. Q.
    ONCOGENE, 2024, 43 (15) : 1160 - 1160
  • [23] RETRACTION: Anti-microRNA-222 (anti-miR-222) and-181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal (Retraction of Vol 286, Pg 42292, 2011)
    Lu, Yuanzhi
    Roy, Satavisha
    Nuovo, Gerard
    Ramaswamy, Bhuvaneswari
    Miller, Tyler
    Shapiro, Charles
    Jacob, Samson T.
    Majumder, Sarmila
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (10) : 3588 - 3588
  • [24] RETRACTED: MiR-132 enhances proliferation and migration of HaCaT cells by targeting TIMP3 (Retracted article. See vol. 11, pg. 5002, 2021)
    Jiang, Lina
    Jiang, Yizhou
    Ji, Xiaohui
    Li, Jiangtao
    Zhai, Ximei
    RSC ADVANCES, 2019, 9 (37) : 21125 - 21133
  • [25] HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
    Andrej Gorbatenko
    Rolf Søkilde
    Ester E. Sorensen
    Inga Newie
    Helena Persson
    Beatriz Morancho
    Joaquin Arribas
    Thomas Litman
    Carlos Rovira
    Stine Falsig Pedersen
    Scientific Reports, 9
  • [26] HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
    Gorbatenko, Andrej
    Sokilde, Rolf
    Sorensen, Ester E.
    Newie, Inga
    Persson, Helena
    Morancho, Beatriz
    Arribas, Joaquin
    Litman, Thomas
    Rovira, Carlos
    Pedersen, Stine Falsig
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [27] Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
    Lindberg, Karolina
    Helguero, Luisa A.
    Omoto, Yoko
    Gustafsson, Jan-Ake
    Haldosen, Lars-Arne
    BREAST CANCER RESEARCH, 2011, 13 (02):
  • [28] Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
    Karolina Lindberg
    Luisa A Helguero
    Yoko Omoto
    Jan-Åke Gustafsson
    Lars-Arne Haldosén
    Breast Cancer Research, 13
  • [29] 3,3′-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1 (vol 129, pg 1781, 2011)
    Ahmad, A.
    Ali, S.
    Wang, Z.
    Ali, A. S.
    Sethi, S.
    Sakr, W. A.
    Raz, A.
    Rahman, K. M.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (09) : E10 - E10
  • [30] 3, 3′-diindolylmethane enhances the effectiveness of Herceptin by upregulation of miR-200 through down-regulation of FoxM1 in breast cancer cells
    Ahmad, Aamir
    Ali, Shadan
    Sakr, Wael
    Rahman, K. M.
    CANCER RESEARCH, 2012, 72
12345